Moderna starts trial testing Omicron-specific booster shot

Reuters2022-01-27

Jan 26 (Reuters) - Moderna Inc said on Wednesday it had dosed the first participant in a mid-stage study testing its Omicron-specific booster vaccine candidate.

The company also reported data showing that neutralizing antibodies against the Omicron COVID-19 variant declined 6.3-fold from peak levels six months after a third booster dose of its vaccine but remained detectable.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
1